Pep'd

Pep'd is a vertically integrated telehealth and life sciences company focused on the therapeutic potential of peptides. The company operates a platform that connects patients across all 50 U.S. states with licensed clinicians for personalized care in metabolic health, longevity, and aesthetics. Beyond its telehealth services, Pep'd conducts research into peptide formulations, delivery methods, and treatment protocols. The company utilizes machine learning to analyze de-identified clinical outcomes data from its platform to inform research priorities and identify novel therapeutic opportunities. Pep'd aims to build a robust portfolio of intellectual property while leveraging AI-enabled approaches to advance the peptide sector. The company is currently generating revenue and maintains a vertically integrated model that includes in-house research and partnerships with compounding pharmacies.